Skip to content

TECNIS IOL ZCT225 (REF ZCT225U305)Recalls & reported problems

Johnson & Johnson Surgical Vision, Inc. · TECNIS TORIC 1-PIECE 6.0MM 30.5D CYL2.25 · Class 3 · Implant

All models of TECNIS IOL (1344)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05050474552944), received between Jan 21, 2021 and Jan 21, 2021 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Toxic Anterior Segment Syndrome (TASS)1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 21, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT A PATIENT DEVELOPED POST-OP INFECTION AFTER INTRAOCULAR LENS (IOL) IMPLANTATION. FURTHER FOLLOW-UP STATED THAT THE CUSTOMER ¿S FACILITY HAS A TOXIC ANTERIOR SEGMENT SYNDROME (TASS) OUTBREAK AND A THOROUGH INVESTIGATION IS BEING DONE BUT A KNOWN CAUSE HAS NOT YET BEEN CONFIRMED. HOWEVER, IT WAS STATED THAT STEROID DROPS WERE GIVEN TO THE PATIENT AS MEDICAL INTERVENTION. THE PATIENT FULLY RECOVERED WITH THE IOL REMAINING IMPLANTED. NO PRODUCT WILL BE RETURNED FOR EVALUATION. NO OTHER INFORMATION WAS PROVIDED.

    Patient problems: Toxic Anterior Segment Syndrome (TASS)

    MAUDE report 11206292 ↗

Other LENS, INTRAOCULAR, TORIC OPTICS devices

All LENS, INTRAOCULAR, TORIC OPTICS devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page